Please login to the form below

Not currently logged in
Email:
Password:

sofosbuvir

This page shows the latest sofosbuvir news and features for those working in and with pharma, biotech and healthcare.

Merck’s appeal to restore hepatitis C patent verdict against Gilead fails

Merck’s appeal to restore hepatitis C patent verdict against Gilead fails

The patent dispute dates back to August 2013, when Merck first contacted Gilead requesting that the company pay royalties on sofosbuvir and obtain a licence to patent. ... Gilead alleged in the lawsuit that Merck had amended its patent application in an

Latest news

More from news
Approximately 28 fully matching, plus 96 partially matching documents found.

Latest Intelligence

  • When science is not enough When science is not enough

    Witness Gilead’s hepatitis C drug sovaldi (sofosbuvir) which has glowing efficacy results yet is having a troubled transition into the market place.

  • Taking a strategic approach Taking a strategic approach

    a warning from the WHO on the cost of new treatments for hepatitis C, with the likes of Gilead's Sovaldi (sofosbuvir) in particular having been a lightning rod for the

  • AbbVie: New firm, new thinking AbbVie: New firm, new thinking

    Gilead Sciences has emerged as the leader in this field with Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir), both of which have already made billions of dollars.

  • Pharma deals during June 2014 Pharma deals during June 2014

    Idenix' negotiation position will have been helped no end by the price and recent US sales of Gilead's Sovaldi (sofosbuvir); the US price is $84, 000 (for a 12 week

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics